Hepatic preconditioning of doxorubicin in stop-flow chemotherapy: NF-κB/IκB-α pathway and expression of HSP72

Figure 4 Serum level of ALT (A) and AST (B) at different time points before and after SFC respectively, 0, before SFC, I20 min, at the end of SFC (20 min), R3h, 3 h after the restoration of the abdominal circulation, R6 h, 6 h after the restoration of the abdominal circulation, R24 h, 24 h after the restoration of the abdominal circulation, R48 h, 48 h after the restoration of the abdominal circulation, R7d, 7 d after the restoration of the abdominal circulation.